论文标题
梯度映射引导的可解释的深神经网络,用于3D头颈癌计算机层析成像图像中的囊外扩展识别
A Gradient Mapping Guided Explainable Deep Neural Network for Extracapsular Extension Identification in 3D Head and Neck Cancer Computed Tomography Images
论文作者
论文摘要
头颈鳞状细胞癌(HNSCC)的诊断和治疗管理通过常规诊断头和颈部计算机断层扫描(CT)扫描来指导,以鉴定肿瘤和淋巴结特征。囊外延伸(ECE)是患者使用HNSCC生存结果的有力预测指标。当ECE改变患者的分期和管理时,必须检测到ECE的发生。当前的临床ECE检测依赖于放射科医生进行的视觉识别和病理确认。近年来,基于机器学习(ML)的ECE诊断表现出很高的潜力。但是,在当前大多数基于ML的ECE诊断研究中,淋巴结区域的手动注释是所需的数据预处理步骤。此外,此手动注释过程耗时,劳动密集型且容易出错。因此,在本文中,我们提出了一个梯度映射引导的可解释网络(GMGENET)框架,以自动执行ECE识别,而无需带注释的淋巴结区域信息。提出了梯度加权类激活映射(GRAD-CAM)技术,以指导深度学习算法以专注于与ECE高度相关的区域。提取无用的无需淋巴结区域信息的知名度(VOI)。在评估中,提出的方法是通过交叉验证,实现测试准确性和90.2%和91.1%的AUC进行良好训练和测试的。 ECE的存在或不存在已分析并与黄金标准的组织病理学发现并相关。
Diagnosis and treatment management for head and neck squamous cell carcinoma (HNSCC) is guided by routine diagnostic head and neck computed tomography (CT) scans to identify tumor and lymph node features. Extracapsular extension (ECE) is a strong predictor of patients' survival outcomes with HNSCC. It is essential to detect the occurrence of ECE as it changes staging and management for the patients. Current clinical ECE detection relies on visual identification and pathologic confirmation conducted by radiologists. Machine learning (ML)-based ECE diagnosis has shown high potential in the recent years. However, manual annotation of lymph node region is a required data preprocessing step in most of the current ML-based ECE diagnosis studies. In addition, this manual annotation process is time-consuming, labor-intensive, and error-prone. Therefore, in this paper, we propose a Gradient Mapping Guided Explainable Network (GMGENet) framework to perform ECE identification automatically without requiring annotated lymph node region information. The gradient-weighted class activation mapping (Grad-CAM) technique is proposed to guide the deep learning algorithm to focus on the regions that are highly related to ECE. Informative volumes of interest (VOIs) are extracted without labeled lymph node region information. In evaluation, the proposed method is well-trained and tested using cross validation, achieving test accuracy and AUC of 90.2% and 91.1%, respectively. The presence or absence of ECE has been analyzed and correlated with gold standard histopathological findings.